| Barry S Herst, MD | |
|
2800 N Sheridan Rd, #103, Chicago, IL 60657 | |
| (773) 525-8200 | |
| (773) 525-8699 |
| Full Name | Barry S Herst |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 47 Years |
| Location | 2800 N Sheridan Rd, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295809259 | NPI | - | NPPES |
| 0342700001 | Other | DME | |
| 0001618089 | Other | BC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Physiciansandsurgeons Of Chicago,s.c. | 8123112588 | 4 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced the completion of a clinical study of Prelude.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.
Facing enormous budget constraints, lawmakers in California have sought to find a way to keep day-care services for adults to help keep them out of nursing homes. Conn. residents face a similar situation because the state is slated to close respite centers that help families get a break from caregiving.
Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) ("Talecris" or the "Company") today announced the closing on October 6 of its initial public offering of shares of common stock, which was priced on September 30 at a public offering price of $19.00 per share.
› Verified 9 days ago
| Entity Name | Eye Physicians&surgeons Of Chicago,s.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306955299 PECOS PAC ID: 8123112588 Enrollment ID: O20070917000540 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced the completion of a clinical study of Prelude.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.
Facing enormous budget constraints, lawmakers in California have sought to find a way to keep day-care services for adults to help keep them out of nursing homes. Conn. residents face a similar situation because the state is slated to close respite centers that help families get a break from caregiving.
Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) ("Talecris" or the "Company") today announced the closing on October 6 of its initial public offering of shares of common stock, which was priced on September 30 at a public offering price of $19.00 per share.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barry S Herst, MD 2800 N Sheridan Rd, #103, Chicago, IL 60657 Ph: (773) 525-8200 | Barry S Herst, MD 2800 N Sheridan Rd, #103, Chicago, IL 60657 Ph: (773) 525-8200 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced the completion of a clinical study of Prelude.
As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.
The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.
Facing enormous budget constraints, lawmakers in California have sought to find a way to keep day-care services for adults to help keep them out of nursing homes. Conn. residents face a similar situation because the state is slated to close respite centers that help families get a break from caregiving.
Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) ("Talecris" or the "Company") today announced the closing on October 6 of its initial public offering of shares of common stock, which was priced on September 30 at a public offering price of $19.00 per share.
› Verified 9 days ago
Paul Owen Phelps, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2001 N Halsted St Ste 200, Chicago, IL 60614 Phone: 312-888-5754 Fax: 833-989-2458 | |
Dr. David Alan Ramirez Jr., MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 225 E Chicago Ave # 70, Chicago, IL 60611 Phone: 312-227-6180 | |
Curtis James Heisel, Ophthalmology Medicare: Medicare Enrolled Practice Location: 251 E Huron St, Chicago, IL 60611 Phone: 312-227-4000 | |
Dr. John B Bello, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7447 W Talcott Ave, Suite 406, Chicago, IL 60631 Phone: 773-775-9755 Fax: 773-775-4306 | |
Adrienne Berman, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jhansi Raju, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3700 W 26th St, Chicago, IL 60623 Phone: 773-542-5203 Fax: 773-542-5841 | |
Catherine Jane Thomas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 1520, Chicago, IL 60611 Phone: 312-695-8150 Fax: 312-503-8152 |